Cargando…

SARS-CoV2 vaccine boosters for India

Detalles Bibliográficos
Autor principal:	Kang, Gagandeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Indian Association of Medical Microbiologists. Published by Elsevier B.V. 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721511/ https://www.ncbi.nlm.nih.gov/pubmed/34991914 http://dx.doi.org/10.1016/j.ijmmb.2021.12.015

Ejemplares similares

SARS-CoV-2 Omicron variant in cancer patients: an insight into the vaccine booster debate
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Tracking SARS-CoV-2 infection in India with serology
por: John, Jacob, et al.
Publicado: (2021)

The third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2021)

Antibody response to SARS-CoV-2 booster vaccines
por: Loving, Hanna S., et al.
Publicado: (2022)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

Does natural and hybrid immunity obviate the need for frequent vaccine boosters against SARS‐CoV‐2 in the endemic phase?
por: Pilz, Stefan, et al.
Publicado: (2022)

Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report
por: Atmar, Robert L., et al.
Publicado: (2021)

SARS-CoV-2 vaccine boosters: The time to act is now
por: Petersen, Maya, et al.
Publicado: (2021)

The societal value of SARS-CoV-2 booster vaccination in Indonesia
por: Johnson, Rob, et al.
Publicado: (2023)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

The SARS-CoV-2 vaccines: Retrospective and perspectives
por: Epaulard, Olivier
Publicado: (2022)

In Pursuit of a SARS-CoV-2 Vaccine
por: Johnson, Alton R., et al.
Publicado: (2020)

SARS-CoV2 vaccines: Slow is fast
por: Green, Douglas R.
Publicado: (2020)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine
por: Wilder-Smith, Annelies, et al.
Publicado: (2021)

The SARS-CoV2 pandemic and routine immunisation
por: Kang, Gagandeep
Publicado: (2022)

Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant
por: Zhang, Wei, et al.
Publicado: (2022)

A booster with SARS-CoV-2 vaccines: protection against Omicron infection
por: Hu, Yuehong, et al.
Publicado: (2022)

Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy
por: Dick, Aharon, et al.
Publicado: (2022)

Rapid Evaluation of Vaccine Booster Effectiveness against SARS-CoV-2 Variants
por: Cheng, Hoi Lok, et al.
Publicado: (2022)

Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2
por: Vasin, Andrey V, et al.
Publicado: (2023)

Impact of maternal SARS-CoV-2 booster vaccination on blood and breastmilk antibodies
por: Rick, Anne-Marie, et al.
Publicado: (2023)

HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
por: Fleury, Herve
Publicado: (2022)

A vaccine for SARS-CoV-2: goals and promises
Publicado: (2020)

Approved mRNA Vaccines for SARS-CoV-2
por: Faiman, Beth
Publicado: (2021)

SARS-CoV-2 Vaccination for Children—An Open Issue
por: Caselli, Désirée, et al.
Publicado: (2021)

Vaccination for SARS-CoV-2 of migrants and refugees, Jordan
por: Bellizzi, Saverio, et al.
Publicado: (2021)

SARS-CoV-2 pandemic in India: what might we expect?
por: Gautam, Sneha, et al.
Publicado: (2020)

Effectiveness of Bivalent Omicron-Containing Booster Vaccines against SARS-CoV-2 Omicron Variant among Individuals with and without Prior SARS-CoV-2 Infection
por: Widyasari, Kristin, et al.
Publicado: (2023)

Vaccine breakthrough infections with SARS-CoV-2: Why older adults need booster vaccinations
por: Ventura, Maria I., et al.
Publicado: (2022)

Influenza vaccination in the time of SARS-CoV-2()
por: Reina, Jordi
Publicado: (2021)

Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer
por: Naranbhai, Vivek, et al.
Publicado: (2022)

Comparative evaluation of SARS-CoV-2 IgG assays in India()
por: Chaudhuri, Susmita, et al.
Publicado: (2020)

Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2
por: Markewitz, Robert, et al.
Publicado: (2022)

Waning immunity to inactive SARS-CoV-2 vaccine in healthcare workers: booster required
por: Balkan, İlker İnanc, et al.
Publicado: (2022)

Seroconversion after SARS-CoV-2 mRNA booster vaccine in cancer patients
por: Patelli, Giorgio, et al.
Publicado: (2022)

288 Minimal Change Disease Relapse After SARS-CoV-2 Booster Vaccine
Publicado: (2022)

The role of booster vaccination and ongoing viral evolution in seasonal circulation of SARS-CoV-2
por: Kraay, A. N. M., et al.
Publicado: (2022)

Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
por: Norddahl, Gudmundur L., et al.
Publicado: (2022)

Booster vaccinations and Omicron: the effects on SARS-CoV-2 antibodies in Dutch blood donors
por: Quee, F. A., et al.
Publicado: (2023)

Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines
por: Kremer, Eric J.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nmqta9u8tlc0qtvlcvbnkcu6ep